Geetha Manjunath

Geetha Manjunath is an Indian entrepreneur and computer scientist. She is the founder and CEO of NIRAMAI Health Analytix, a Bengaluru based start-up that provides non-invasive, radiation free breast cancer screening through AI.

Education

Raised in Bengaluru, Manjunath got her Bachelor's in Computer Science from UVCE, and got her Master's from IISc in Computer Science. She holds a management education from Kellogg School of Management, Chicago and a PhD from IISc in AI and Data Mining. That's when she was transferred to the research wing.

She then joined Hewlett-Packard Laboratories as a Principal Research Scientist where she worked for 17 years, and later worked as the Lab Director leading Data Analytics Research at Xerox India.

In 2016, she became an entrepreneur by establishing her start-up NIRAMAI along with Nidhi Mathur.

The start-up announced in 2019, that it would leverage Thermalytix in detecting the presence of parasitic worm that causes river blindness, a project that is being also funded by the Bill and Melinda Gates Foundation.

In 2021, through NIRAMAI, Manjunath collaborated with Non-profit organization Artpark CEO Umakant Soni and IISc to come up with X-RaySetu. It is an AI-based program that runs on the app WhatsApp to help detect Covid-19 in areas where CT scans and RT-PCR tests aren't available. Manjunath is the has 16 US Patents for her work. In June 2021, Indian-American computer scientist Dr. Geetha Manjunath was named as one of the recipients of the Women Tech Global Awards in the "Innovator of the Year" category. Dr. Manjunath is the CEO and co-founder of Niramai, a startup that uses AI-based technology for early detection of breast cancer.